^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
MPT0L145
i
Other names: MPT0L145
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Taipei Medical University
Drug class:
FGFR inhibitor, PIK3C3 inhibitor
Related drugs:
